Array BioPharma Financial Statements
Array BioPharma Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | June |
© 2009 Morningstar, Inc. Financial Data provided by
Array BioPharma Income Statement
| 2009 | 2008 | 2007 | |
|---|---|---|---|
| Revenue ($ mil.) | 25.0 | 28.8 | 37.0 |
| Gross Profit ($ mil.) | 5.1 | 7.4 | 12.0 |
| Operating Income ($ mil.) | (118.1) | -- | -- |
| Total Net Income ($ mil.) | (127.8) | (98.2) | (55.4) |
| Diluted EPS (Net Income) | (2.67) | (2.04) | (1.36) |
Array BioPharma Quarterly Statements
| Quarter Ending Sep 09 | Quarter Ending Jun 09 | Quarter Ending Mar 09 | |
|---|---|---|---|
| Revenue ($ mil.) | 7.9 | 5.5 | 6.0 |
| Gross Profit ($ mil.) | 2.0 | 1.4 | 0.5 |
| Operating Income ($ mil.) | -- | -- | -- |
| Total Net Income ($ mil.) | (24.8) | (26.7) | (29.6) |
| Diluted EPS (Net Income) | (0.52) | (0.55) | (0.62) |
Array BioPharma Stock Quote & Chart
11/06/09 16:00:02 EST •
NASDAQ •
2.00
•
 -0.0200
•
-0.9901 %
|
|---|
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
|
Array BioPharma Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 3.54 | 1.52 | 7.01 |
| Price/Earnings Ratio | (0.81) | 18.69 | 25.51 |
| Price/Book Ratio | (1.20) | 2.57 | 6.74 |
| Price/Cash Flow Ratio | (1.04) | 11.61 | 43.48 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Array BioPharma Financial Ratios
Array BioPharma Competitive Intelligence
| ArQule | Theravance | Vertex Pharmaceuticals | |
|---|---|---|---|
| Annual Sales ($ mil.) | 14.1 | 23.1 | 175.5 |
| Employees | 107 | 191 | 1,333 |
| Market Cap ($ mil.) | 153.7 | 788.6 | 6,998.7 |
Competitive Landscape
